1. 1009PDThe identification of the AXL/Gas6 signalling axis as a key player of myelodysplastic syndrome (MDS) and the potential of the oral selective AXL inhibitor bemcentinib in the treatment of MDS. (23rd October 2018) Authors: Medyouf, H; Tirado-Gonzalez, I; Mies, A; Nevmerzhitskaya, A; Kubasch, A-S; Platzbecker, U Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Serum biomarkers for the diagnosis of chronic recurrent multifocal osteomyelitis (CRMO). Issue 1 (December 2015) Authors: Hofmann, S; Kubasch, A-S; Range, U; Laass, M; Rösen-Wolff, A; Schwarz, T; Hofmann, C; Girschick, H; Morbach, H; Hedrich, C Journal: Pediatric rheumatology online journal Issue: Volume 13:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Serum biomarkers for the diagnosis of chronic recurrent multifocal osteomyelitis (CRMO). Issue 1 (December 2015) Authors: Hofmann, S; Kubasch, A-S; Range, U; Laass, M; Rösen-Wolff, A; Schwarz, T; Hofmann, C; Girschick, H; Morbach, H; Hedrich, C Journal: Pediatric rheumatology online journal Issue: Volume 13:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗